Phillips 66 (PSX) Q2 earnings beat: refining margins, EBITDA, debt reduction and buybacks. Click to read my analysis for more details on the pros and cons.

MARKETS4M AGO

Iridium: A Merger-Arb Hold At Current Levels

Iridium (IRDM) rated Hold with $48 target amid Rocket Lab merger.

MARKETS7M AGO

Opus Genetics: A Resounding Study Success Merits A Higher Valuation

Opus Genetics (IRD) receives a Buy rating following >30% stock surge on positive Phase 1/2 data for OPGx-BEST1 in BEST1-related retinal diseases. Click to read.

MARKETS10M AGO

Shoe Station Q2: Not The Value Stock To Invest In Currently

Shoe Station Group Inc. stock plunged after weak Q2 earnings and lowered FY2026 guidance. Click for this SHOE earnings update.

MARKETS11M AGO

More in Markets

Yuanbao Inc. (YB) Q2 2026 Earnings Call Transcript

Phillips 66: I Was Wrong On The Duration, Not On The Cycle

Iridium: A Merger-Arb Hold At Current Levels

Opus Genetics: A Resounding Study Success Merits A Higher Valuation

Shoe Station Q2: Not The Value Stock To Invest In Currently

Comstock's Solar-Recycling Pivot: Big Nameplate Capacity, Missing Feedstock